Response and Adverse Effects of Nilotinib in Imatinib-Resistant Chronic Myeloid Leukemia Patients: Data from a Developing Country

Shabneez Hussain, Usman Shaikh

Research output: Contribution to journal › Letter › peer-review

Access to Document

@article{4ffad031b2c140a3af139ce70928ea53,

title = "Response and Adverse Effects of Nilotinib in Imatinib-Resistant Chronic Myeloid Leukemia Patients: Data from a Developing Country",

author = "Shabneez Hussain and Usman Shaikh",

year = "2016",

month = mar,

day = "1",

doi = "10.1016/j.clinthera.2016.01.002",

language = "English",

volume = "38",

pages = "681--682",

journal = "Clinical Therapeutics",

issn = "0149-2918",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - Response and Adverse Effects of Nilotinib in Imatinib-Resistant Chronic Myeloid Leukemia Patients

T2 - Data from a Developing Country

AU - Hussain, Shabneez

AU - Shaikh, Usman

PY - 2016/3/1

Y1 - 2016/3/1

UR - http://www.scopus.com/inward/record.url?scp=84960941452&partnerID=8YFLogxK

U2 - 10.1016/j.clinthera.2016.01.002

DO - 10.1016/j.clinthera.2016.01.002

M3 - Letter

C2 - 26831828

AN - SCOPUS:84960941452

SN - 0149-2918

VL - 38

SP - 681

EP - 682

JO - Clinical Therapeutics

JF - Clinical Therapeutics

IS - 3

ER -